ResearchMoz

Liver Cancer Global Clinical Trials Review, H2, 2012

GlobalData
Published Date » 2012-12-12
No. Of Pages » 159
     
  Liver Cancer Global Clinical Trials Review, H2, 2012  
     
  Summary  
   
 GlobalData's clinical trial report, Liver Cancer Global Clinical Trials Review, H2, 2012" provides data on the Liver Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Liver Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Liver Cancer. This report is built using data and information sourced from proprietary databases, primary...
Table of Contents

Table of Contents 2

List of Tables 5
List of Figures 6
Introduction 7
Liver Cancer 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Five Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Liver Cancer 24
Subjects Recruited Over a Period of Time 36
Prominent Sponsors 37
Top Companies Participating in Liver Cancer Therapeutics Clinical Trials 39
Prominent Drug Comparison 41
Clinical Trial Profiles 42
Clinical Trial Overview of Top Companies 42
Bayer AG 42
Clinical Trial Overview of Bayer AG 42
Bristol-Myers Squibb Company 44
Clinical Trial Overview of Bristol-Myers Squibb Company 44
Pfizer Inc. 45
Clinical Trial Overview of Pfizer Inc. 45
Taiho Pharmaceutical Co., Ltd. 46
Clinical Trial Overview of Taiho Pharmaceutical Co., Ltd. 46
Sanofi 47
Clinical Trial Overview of Sanofi 47
Novartis AG 48
Clinical Trial Overview of Novartis AG 48
Celsion Corporation 49
Clinical Trial Overview of Celsion Corporation 49
Pathfinder Therapeutics, Inc. 50
Clinical Trial Overview of Pathfinder Therapeutics, Inc. 50
AstraZeneca PLC 51
Clinical Trial Overview of AstraZeneca PLC 51
Jennerex Biotherapeutics, Inc. 52
Clinical Trial Overview of Jennerex Biotherapeutics, Inc. 52
GlaxoSmithKline plc 53
Clinical Trial Overview of GlaxoSmithKline plc 53
Eli Lilly and Company 54
Clinical Trial Overview of Eli Lilly and Company 54
F. Hoffmann-La Roche Ltd. 55
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 55
Merck & Co., Inc. 56
Clinical Trial Overview of Merck & Co., Inc. 56
Light Sciences Oncology, Inc. 57
Clinical Trial Overview of Light Sciences Oncology, Inc. 57
Kowa Company, Ltd. 58
Clinical Trial Overview of Kowa Company, Ltd. 58
ArQule, Inc. 59
Clinical Trial Overview of ArQule, Inc. 59
BioAlliance Pharma SA 60
Clinical Trial Overview of BioAlliance Pharma SA 60
Eisai Inc. 61
Clinical Trial Overview of Eisai Inc. 61
Bio-Cancer Treatment International Limited 62
Clinical Trial Overview of Bio-Cancer Treatment International Limited 62
Clinical Trial Overview of Top Universities / Institutes / Hospitals 63
Eastern Hepatobiliary Surgery Hospital 63
Clinical Trial Overview of Eastern Hepatobiliary Surgery Hospital 63
The University of Texas M. D. Anderson Cancer Center 66
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 66
Sun Yat-sen University 69
Clinical Trial Overview of Sun Yat-sen University 69
FUDAN University 71
Clinical Trial Overview of FUDAN University 71
Memorial Sloan Kettering Cancer Center 73
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 73
National Taiwan University Hospital 75
Clinical Trial Overview of National Taiwan University Hospital 75
Massachusetts General Hospital 76
Clinical Trial Overview of Massachusetts General Hospital 76
National Cancer Center Hospital 78
Clinical Trial Overview of National Cancer Center Hospital 78
University of Pittsburgh 79
Clinical Trial Overview of University of Pittsburgh 79
Stanford University 80
Clinical Trial Overview of Stanford University 80
Seoul National University Hospital 81
Clinical Trial Overview of Seoul National University Hospital 81
West China Hospital 82
Clinical Trial Overview of West China Hospital 82
University Health Network 83
Clinical Trial Overview of University Health Network 83
Kaohsiung Medical University Chung-Ho Memorial Hospital 84
Clinical Trial Overview of Kaohsiung Medical University Chung-Ho Memorial Hospital 84
University of Milan 85
Clinical Trial Overview of University of Milan 85
Roswell Park Cancer Institute 86
Clinical Trial Overview of Roswell Park Cancer Institute 86
Mayo Clinic 87
Clinical Trial Overview of Mayo Clinic 87
Kurume University 88
Clinical Trial Overview of Kurume University 88
Queen Mary Hospital 89
Clinical Trial Overview of Queen Mary Hospital 89
Kyoto University 90
Clinical Trial Overview of Kyoto University 90
Five Key Clinical Profiles 91

Appendix 156
Abbreviations 156
Definitions 156
Research Methodology 157
Secondary Research 157
About GlobalData 158
Contact Us 158
Disclaimer 158
Source 159

List of Tables


Liver Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8
Liver Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
Liver Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 11
Liver Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12
Liver Cancer Therapeutics Clinical Trials, North America, Top Five Countries, 2012* 13
Liver Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012* 14
Liver Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 15
Liver Cancer Therapeutics Clinical Trials, BRIC Countries, 2012* 16
Liver Cancer Therapeutics Clinical Trials, G7 Countries, 2012* 17
Liver Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
Liver Cancer Therapeutics Clinical Trials, E7 Countries, 2012* 19
Liver Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
Liver Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012* 21
Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 22
Liver Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Liver Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2012* 24
Liver Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 26
Liver Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2012* 28
Liver Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 36
Liver Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 38
Liver Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 40
Liver Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 41
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012* 42
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012* 44
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 45
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Taiho Pharmaceutical Co., Ltd., 2012* 46
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012* 47
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 48
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Celsion Corporation, 2012* 49
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pathfinder Therapeutics, Inc., 2012* 50
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 51
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Jennerex Biotherapeutics, Inc., 2012* 52
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 53
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012* 54
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012* 55
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 56
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Light Sciences Oncology, Inc., 2012* 57
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Kowa Company, Ltd., 2012* 58
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by ArQule, Inc., 2012* 59
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by BioAlliance Pharma SA, 2012* 60
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012* 61
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bio-Cancer Treatment International Limited, 2012* 62
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Hepatobiliary Surgery Hospital, 2012* 63
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 66
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2012* 69
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2012* 71
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012* 73
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2012* 75
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012* 76
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Center Hospital, 2012* 78
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2012* 79
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012* 80
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2012* 81
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by West China Hospital, 2012* 82
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2012* 83
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Kaohsiung Medical University Chung-Ho Memorial Hospital, 2012* 84
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Milan, 2012* 85
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012* 86
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 87
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Kurume University, 2012* 88
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen Mary Hospital, 2012* 89
Liver Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2012* 90

List of Figures


Liver Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8
Liver Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
Liver Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 11
Liver Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 12
Liver Cancer Therapeutics Clinical Trials, North America, Top Five Countries (%), 2012* 13
Liver Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012* 14
Liver Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 15
Liver Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2012* 16
Liver Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012* 17
Liver Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
Liver Cancer Therapeutics Clinical Trials, E7 Countries (%), 2012* 19
Liver Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
Liver Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 21
Liver Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 22
Liver Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Liver Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 36
Liver Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 37
Liver Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 39
Liver Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 41
GlobalData Methodology 157

Upcoming Reports:

Multi-Factor Authentication Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
The global multi-factor authentication (MFA) market has shown remarkable progress in the recent years and is also showing attractive market potential for the future. North America and Europe hold the largest market share of the global MFA market and Asia-Pacific is expected to be the fastest growing region in the coming years. The market is segmented into three major categories on the basis of model types into: two factor authentication, three factor authentication, and four factor authentication. It is divided into five major categories on the basis of applications into government,...
Greece: frozen pig meat market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the frozen pig meat market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the frozen pig meat market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview...
Utility And Industrial Boilers Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2014 - 2020
By - Transparency Market Research
Boilers are closed vessels used for generation of steam by supplying heat energy to water. Various kinds of energy sources such as fossil fuels, nuclear fuels, biomass and solar energy are used to generate steam. Boilers can be divided into two types based on their process as water-tube and fire-tube boilers. In water-tube boilers, tubes filled with water are heated using combustion gases flowing outside the tubes, whereas in fire tube boilers, hot combustion gases flowing inside the tubes are used to heat the water that flows outside the tubes.  Further, boilers are...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

New Drug Shows Early Promise against Heart Attacks and Strokes
Sep 1, 2014  
Sanofi and Regeneron Pharmaceuticals have been working on a new experimental drug that aims to lower cholesterol. Early tests have shown that the drug cuts down risks of heart attacks and strokes in clinical trials by half. The test report says that the results are not conclusive as the analysis was performed retrospectively. The study does provide the positive result that...
Western Africa economies hit by Ebola travel ban
Aug 28, 2014  
With over 1,400 people dead due to the fatal Ebola outbreak in African countries, travel services have either banned or limited operations to the western region, severely hitting economies of the area. Budgetary resources are being utilized rapidly and economic growth has dropped by 4% as international projects and trips have been cancelled. Transport companies have cut off the region...
Fonterra Ties Up With Beingmate to Tap into China’s Baby Food Market
Aug 28, 2014  
Fonterra Co-Operative Group Ltd. will partner with Beingmate Group Co, China’s biggest infant formula manufacturer to increase its reach in the Chinese market. The New Zealand-based company makes this move with the intent to grab a bigger market share in China after it suffered many setbacks in the food-safety scandal last year.   This partnership will also help Beingmate...
Chinas Leading Asset-Management Company Aims for IPO
Aug 28, 2014  
China’s biggest asset-management company plans to go public by the end of 2015. Chinese authorities are constantly ramping up their interests towards introducing mixed ownership to state-owned huge companies and call for more private capital investments into the economy. According to the news report, China Huarong Asset Management Co., Ltd. will collaborate with eight investors...
Warren Buffet Helps Burger King with Tim Horton Deal
Aug 27, 2014  
Renowned investor Warren Buffet plans to finance Burger King Worldwide Inc.’s acquisition of Tim Hortons Inc., the Canadian coffee chain. Berkshire Hathaway Inc., Warren Buffet’s firm will invest through preferred shares, it is speculated. Nearly 25% of the deal’s financing would be handled by Berkshire. The precise aim for Warren Buffet’s participation is yet...